• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

La Jolla Pharmaceutical Co

+ Add to Watchlist

LJPC:US

11.0900 USD 0.0400 0.36%

As of 20:10:00 ET on 04/24/2014.

Snapshot for La Jolla Pharmaceutical Co (LJPC)

Open: 11.0800 Day's Range: 10.6150 - 11.1700 Volume: 163,057
Previous Close: 11.0500 52wk Range: 2.7813 - 19.5000 1-Yr Rtn: +177.25%

Stock Chart for LJPC

No chart data available.
  • LJPC:US 11.0900
  • 1D
  • 1M
  • 1Y
11.0500
Interactive LJPC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LJPC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -97.7400
Est. EPS (USD) (12/2014) -2.8200
Est. PEG Ratio -
Market Cap (M USD) 80.48
Shares Outstanding (M) 7.26
30 Day Average Volume 375,625
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LJPC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LJPC

La Jolla Pharmaceutical Company researches and develops specialized therapeutics for the treatment of diseases caused by antibodies. The Company is developing products to treat autoimmune conditions such as lupus and antibody-mediated stroke.

George F TidmarshPresident/CEO/SecretaryJames RolkeSenior Dir:Research And Dev
Stacey RuizDirector:Research & DevelopmentChester S Zygmont IIIDirector: Finance
More Company Profile & Key Executives for LJPC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil